Evidence map›Paper›PMID 35510556›Full record

ArticleDermatologic therapy2022

New-onset bullous pemphigoid and flare of pre-existing bullous pemphigoid after the third dose of the COVID-19 vaccine.

Federico Bardazzi, Miriam Anna Carpanese, Diego Abbenante, Federica Filippi, Lidia Sacchelli, Camilla Loi

Abstract readLetter
In one paragraph

Article in Dermatologic therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Federico BardazziDermatology Unit, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Bologna, Italy.
Miriam Anna CarpaneseDermatology Unit, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Bologna, Italy.
Diego AbbenanteDermatology Unit, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Bologna, Italy.ORCID 0000-0002-5114-865X
Federica FilippiDermatology Unit, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Bologna, Italy.ORCID 0000-0001-8173-4257
Lidia SacchelliDermatology Unit, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Bologna, Italy.ORCID 0000-0003-4388-4523
Camilla LoiDermatology Unit, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Bologna, Italy.ORCID 0000-0001-6700-9534

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Pemphigoid, BullousAutoantibodiesCOVID-19 VaccinesHumansImmunoglobulin GAutoantibodiesCOVID-19 VaccinesImmunoglobulin G

Identifiers

PMID35510556
PMCPMC9347770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.